clusters, but the determinants of cluster size are unknown. We hypothesized that longer duration of symptoms prior to initiation of tuberculosis therapy would be associated with increased cluster size. All patients with tuberculosis in Harris County, Texas, identified between 10/1/95 and 12/31/97 through a prospective populationbased project were interviewed, had their medical records reviewed, and had M. tuberculosis isolates molecularly characterized. There were 506 symptomatic, evaluable patients in 74 clusters, ranging in size from 2 patients (32 clusters) to 61 patients (1 cluster). The median duration of symptoms was 46 days (range, 1-471 days). There was no association between the log-transformed duration of symptoms and cluster size in univariate or multivariate analysis. In multivariate analysis, age and HIV coinfection were inversely related to cluster size, but only weakly. The size of molecularly defined clusters of tuberculosis was not related to the duration of symptoms of most patients who belonged to clusters.
ample, there is now good evidence that cases of symptomatic disease with both primary infection and reinfection are more common than previously believed [2, [6] [7] [8] . Similarly, molecular profiling has allowed the identification of clusters of tuberculosis not recognized by traditional contact investigation, which is limited by patient recall, interviewer skills, and financial resources [7, [9] [10] [11] [12] .
Previous studies in the United States have shown that patients belonging to molecularly defined clusters of tuberculosis are more likely than are patients not in clusters to be young, male, black or Hispanic, and US born; to have a history of homelessness or drug and alcohol use; and to have pulmonary disease, drugresistant disease, or disease due to M. tuberculosis strains belonging to principal genetic groups 1 or 2 [2, 3, 6, 7, 10, [13] [14] [15] [16] [17] [18] . Large single clusters have been described and related to delays in diagnosis and treatment [19] [20] [21] [22] [23] . The role of HIV coinfection remains unclear, with some studies finding an increase in clustering of tuberculosis with HIV infection [3, 6, 7, 17, 24] and others finding no association [2, 10, 15, 25] . Although these factors may help explain why clusters develop, they do not explain why some clusters become larger than others. We hypothesized that delays in the diagnosis and treatment of tuberculosis would be associated with increased transmission of disease, and that this increased transmission would be evident as larger cluster size. We used data from a population-based, prospective study of all patients who received a diagnosis of tuberculosis during a 26-month period in Harris County, Texas, which includes the city of Houston, to test this hypothesis.
METHODS
As part of an ongoing, prospective, population-based study, all residents of Harris County, Texas, who receive a diagnosis of tuberculosis are identified. Patients are interviewed, M. tuberculosis isolates analyzed, and medical records reviewed. Patients who received a diagnosis of tuberculosis before 1 October 1995 or within 3 months after their arrival in Harris County were excluded as nonincident cases. The present study includes incident cases identified between 1 October 1995 and 31 December 1997, the last date for which complete medical record reviews were available when this analysis was initiated. On the basis of the M. tuberculosis molecular profile, patients were classified into 2 groups. "Nonclustered" patients were those whose isolate had a unique profile. "Clustered" patients were those whose isolate perfectly matched that of at least 1 other isolate. Cluster size was defined as the number of patients with isolates that shared the exact same molecular profile. Because this study is focused on symptoms, asymptomatic patients and those whose records were unavailable were excluded; however, their isolates could contribute to defining a cluster.
Trained research assistants interviewed patients in person. A proxy was interviewed if the patient was unavailable or too young. The standardized instrument collects demographic information, a detailed social history, and self-reported medical history. Trained staff blinded to the patient's cluster status reviewed city and county tuberculosis control records and inpatient and outpatient medical records, obtaining data on medical history, symptoms, diagnoses, treatment, and outcome. Symptom onset was noted as it was recorded by the treating physician or tuberculosis control officials. Since a specific date of onset of symptoms was rarely available, duration of symptoms was defined in all cases as the number of days from the first day of the month of onset of any symptom attributed to tuberculosis, as recorded by the provider in the medical record, until the first day of appropriate tuberculosis therapy or death, whichever came first. Appropriate therapy was defined as the initiation of a multidrug regimen, as recorded in the medical records. A case was considered to be acid-fast bacilli (AFB) smear-positive if any sample from a pulmonary site (including gastric aspirates from children) yielded positive AFB smear results.
Molecular characterization was performed according to established methods. In brief, DNA extraction and restriction fragment-length polymorphism (RFLP) analysis with IS6110 element as a probe were performed using an internationally standardized method [26] , and results were analyzed with the BioImage Whole Band Analysis program version 3.2 (BioImage). Isolates containing !5 IS6110 elements were spoligotyped [27] with a commercially available kit (Isogen Bioscience BV). Spoligotyping is an alternative method for molecular characterization of M. tuberculosis isolates. It is independent of the internationally standardized IS6110 RFLP method, because the 2 techniques are based on different target genes (direct repeat [DR] region and IS6110, respectively). The DR region contains both identical direct repeats and unique spacer sequences. The spoligotyping method is based on the analysis of the presence or absence of the 43 selected spacer regions. Spoligotyping is less discriminative than RFLP for those isolates that have 15 copies of IS6110 but gives better differentiation of those isolates that have !5 copies. Combining the 2 methods thus more reliably identifies clusters. Principal genetic group was determined by DNA sequence polymorphism at codon 463 of the catalase-peroxidase gene and codon 95 of the A subunit of the DNA gyrase gene [18] . The first available respiratory isolate from each patient was characterized.
The relationship between the log 10 -transformed duration of symptoms and cluster size was assessed with linear regression. Univariate analysis of other potential determinants of cluster size was also assessed with linear regression, and a multivariate model was created. Data were analyzed with SAS (SAS Institute) and Stata (Stata Corporation) software.
All participants gave written informed consent, and the Baylor College of Medicine and Affiliated Hospitals Institutional Review Board (Houston, TX) approved the study. The research was conducted in accordance with Baylor College of Medicine's guidelines for research involving human subjects.
RESULTS
Tuberculosis was diagnosed in 1448 patients during the study period. Twenty-three patients recevied a misdiagnosis of tuberculosis, 72 declined to enroll in the study, 88 could not be located, and 113 were classified as nonincident cases, leaving 1152 incident cases of tuberculosis. Isolates could not be characterized in 282 of these cases (in most cases, the diagnosis was made without culture results; alternatively, a specimen was not received by or failed to grow in our laboratory), and 330 patients had unique isolates. Isolates from the remaining 540 patients could be grouped into 74 different clusters (mean clus- ter size, 7.3 patients per cluster; median cluster size, 3 patients per cluster; table 1). The medical charts of 9 patients were not available, and 24 patients were asymptomatic at diagnosis. One patient who belonged to a cluster of 52 cases had a duration of symptoms of 1622 days (13 times longer than that of any other patient) and was excluded as an outlier. As a result, 506 clustered patients were analyzed. Patient characteristics are presented in table 2. The median age was 40 years, and 74.7% of the patients were men. Only 12.6% of the patients were not US born; 21.7% were nonHispanic white, 54.4% were non-Hispanic black, and 20.6% were Hispanic. Many patients had histories of homelessness (28.5%) and incarceration (65.7%). Substance use was common: 59.2% of patients were currently smoking, 44.4% were using alcohol daily or nearly daily, and 52.9% had ever used illicit drugs. HIV infection was the most common comorbid condition, in 27.5% of patients. Other medical risk factors for tuberculosis were uncommon (data not shown). Cough was present in 85.0% of patients. Most patients (79.6%) had exclusively pulmonary disease; 9.3% had exclusively extrapulmonary disease, and 11.1% had both. No patients had laryngeal tuberculosis. Sputum was AFB smear-positive in 56.3% of all patients, and in 62.1% of patients with pulmonary disease; cavitary disease was present in 36.0% of all patients and in 39.7% of patients with pulmonary disease. Drug-resistant strains of M. tuberculosis were isolated from 8.7% of patients, and 0.6% of patients had strains with multidrug resistance (isoniazid and rifampin resistance). Most patients received directly observed therapy (85.2%) and 4-drug therapy (87.0%), in accordance with published guidelines [28] . The mean duration of treatment was 266 days, which did not vary by cluster size. Fourteen patients with postmortem diagnosis of tuberculosis were never treated.
The duration of symptoms prior to initiation of tuberculosis therapy ranged from 1 to 471 days, with a median duration of 46 days and an interquartile range of 25-83 days. The association between duration of symptoms and cluster size is presented in figure 1. There was no relationship between duration of symptoms and cluster size, whether examining the mean, the median, or the 25th or 75th percentile values for the duration of symptoms. In univariate linear regression, an increase of symptom duration of 1 log (i.e., an increase from 10 days to 100 days of symptoms) was associated with an increase in cluster size of 1 patient, which was neither clinically nor statistically significant ( ). P p .62 In a univariate analysis of the association between other variables and cluster size (table 2), we found that greater cluster size was associated with the following variables: male sex, being US-born, a history of incarceration or homelessness, bus riding at least once per week, use of illicit drugs (ever), current smoking, and initial treatment with a 4-drug regimen. Decreased cluster size was associated with Hispanic ethnicity and with having exclusively extrapulmonary disease. In a multivariate model of cluster size, which considered all of the variables in the univariate analysis, duration of symptoms was still not significantly associated with cluster size (regression coefficient, 0.79;
). The only variables independently associated P p .71 with cluster size were HIV infection and age. The average adjusted size of clusters of HIV-positive patients was 4.9 patients smaller than that of clusters of HIV-negative patients (P p ), and for each 10-year increase in age there was a decrease .04 in adjusted cluster size of 1.5 patients (
). The full model P p .04 with 27 variables had an adjusted R 2 of only 3.4%. None of the variables examined were collinear, nor were there significant first-order interactions between duration of symptoms and age, sex, race, or HIV status, or between cough and the presence of pulmonary disease.
We examined whether excluding the 24 asymptomatic case patients might have introduced error into these results. These patients were found randomly dispersed through the various cluster sizes, and including them in the analysis with an assigned duration of symptoms of 0.5 days did not alter the conclusions above. Similarly, excluding patients with exclusively extrapulmonary disease did not change the relationship between cluster size and duration of symptoms. Finally, we examined the basic demographic information for the 160 patients who were not included in the study because they could not be located or ). It is impossible P ! .01 to predict how inclusion of these patients in the study would have changed the results, but on the basis of these characteristics, many of these patients would be expected to not be members of a cluster.
DISCUSSION
This is the first study to assess the relationship between symptom duration and cluster size among patients with tuberculosis. Using data on 1500 patients, we were unable to demonstrate an association between duration of symptoms prior to treatment and cluster size, using either univariate or multivariate analysis. The only independent predictors of cluster size in this study were age and the presence of HIV infection, both of which were inversely related to cluster size.
It is possible that a single patient or a small number of patients with tuberculosis are responsible for the propagation of clusters, which would not be well reflected in each cluster's mean or median duration of symptoms. However, if this were the case, traditional contact tracing should be more successful than it is in identifying clusters [7, [9] [10] [11] [12] . Alternatively, the increased duration of symptoms in some patients in large clusters may be offset by more aggressive contact tracing among the populations in these clusters, leading to earlier treatment of other members of the cluster. The lack of association between cluster size and the 75th percentile of the value for duration of symptoms argues against this alternative. It is also possible that there are clusters within clusters that function independently of one another and that cannot be analyzed in a summary fashion. These clusters within clusters would then be misclassified as large, biasing results towards the null. Examination of figure 1 suggests that, even if the analysis were limited to the clusters of size 19 patients or smaller-or even 10 patients or smaller-to reduce this misclassification error, there is still no evident association between cluster size and duration of symptoms. Finally, we may not be able to reject the null hypothesis because of inadequate sample size, despite having used data on 1500 patients.
Age was independently inversely related to cluster size. To test whether young patients with HIV were responsible for this finding, data for HIV-infected case patients were deleted from the analysis, and age remained an independent predictor of cluster size. Given the greater social isolation [29] and lower rates of homelessness [30] found with advancing age, the inverse relationship between age and cluster size is not surprising.
HIV coinfection was also independently inversely related to cluster size. This finding is not intuitive, as previous research has found that HIV infection increases the risk of belonging to a cluster of tuberculosis cases [3, 6, 7, 17, 24] . But that research is focused on whether or not a case patient is clustered, rather than on the size of the cluster. The present data may refine our understanding of tuberculosis clustering and HIV infection: HIV-infected patients are more likely to belong to clusters, but as cluster size increases, the proportion of HIVinfected persons decreases. This finding, however, must be interpreted with caution and should be confirmed in other studies, because it emerged only on multivariate analysis.
Most of the larger cluster size categories (i.e., 15 patients per cluster) comprised single clusters (table 1) . This fact leads to 2 additional observations. First, given that the duration of symptoms, the kinds of symptoms, and the proportion of patients with pulmonary, AFB smear-positive, and cavitary disease were similar across all cluster sizes (table 2), it is possible that the different strains of M. tuberculosis result in clinically indistinguishable disease. Studies to confirm this observation are needed, because there are animal model and human data that suggest otherwise [31, 32] , and there are both in vivo and in vitro data suggesting that strains vary in their ability to induce a host immune response [33] . Second, the strains responsible for the larger clusters may be more infectious than the other strains. Previously, we reported that strains belonging to principal genetic groups 1 and 2 were significantly more likely to cause large case clusters [18] . The clusters in this study largely conform to that pattern. These 2 observations are valid only if the patients' access to care and severity of symptoms did not vary with cluster size. This study was not designed to assess these important factors.
The prospective, population-based design of this study and the near-universal access to medical records limit opportunities for selection bias. However, the study does have a number of limitations. First, we were unable to include culture-negative cases in the analysis. However, 75.5% of all tuberculosis cases identified were molecularly characterized. Of the 271 evaluable patients whose M. tuberculosis isolates were not molecularly characterized, more than one-half presented a low transmission risk (14.0% were asymptomatic, 32.5% had only extrapulmonary disease, and 7.0% were children), compared with about 15% of the patients in the present analysis. Second, the symptom data is based on patient recall and physician records. Nonrandom recall bias should be limited, because all patients had tuberculosis, and because the timing of the interview and the use of a proxy for the interview (11% of patients overall) did not differ by cluster size (data not shown). Third, given the high prevalence of cough and smoking in the study, patients may have misattributed a "smoker's cough" to tuberculosis, making the symptom data unreliable. Only 3.8% of the patients in this analysis both smoked and had cough as their only symptom, so this error, if present, should not be large. Fourth, the date of symptom onset was defined as the first day of the month during which symptoms were first noted, to avoid negative duration of symptom values. This definition should have negligible effects on the results, because adding a constant to all values in a linear regression changes the intercept but does not change the other coefficients [34] . Fifth, as an analysis of an ongoing study, the present study excludes patients who received a diagnosis of tuberculosis within 3 months after their arrival in Harris County. M. tuberculosis isolates characterized for 38 of the 113 case patients were excluded for this reason, and almost 75% were unique, so it is unlikely that including nonincident cases would have changed our results. Sixth, the statistical analysis assumes that the data are independent, which may not be the case if the clusters have biological and epidemiological meaning. Nonindependence of the data could artificially decrease variance and so might yield falsely positive results. Because this was a negative study, this limitation is largely academic.
We previously reported, in an abstract based on the data reported herein [35] , that there was an association between cluster size and duration of symptoms. That analysis was less rigorous because clusters were dichotomized into small clusters (2 or 3 persons per cluster) and large clusters (у4 persons per cluster), and nontransformed data on duration of symptoms were compared between the 2 groups with use of Student's t test and multivariate logistic regression [35] . The present analysis is preferred because it uses the actual value of the cluster size as the dependent value, more fully utilizing the available data, and is based on log-transformed data for duration of symptoms, which gives the duration of symptoms data a more normal distribution.
In this population-based study of molecularly-defined clusters of tuberculosis, we found no evidence that duration of symptoms was associated with cluster size. The multivariate models in this study explain very little of the variance in the data, suggesting that the determinants of cluster size are not uniform across the different clusters. Clusters of tuberculosis infections appear to be unique entities whose size is determined by the sociological and epidemiologic properties of the population at risk, as well as by the biological properties of the host and the strain of M. tuberculosis responsible for the cluster. Given this inability to identify factors strongly associated with cluster size, continued aggressive contact tracing, efforts to identify individual clusters both epidemiologically and molecularly, as well as research to understand how patient and health system factors influence cluster size, are justified. dora Davis, Loretta Jackson, and Tony Prejean, for interviewing the study participants.
